Thank you for reaching out! Our team will overview your inquiry and get back again for you immediately.In October 2024, Novo Nordisk revealed a examine on scientific journal Character about a novel glucose-delicate insulin NNC2215 which can decrease the potential risk of hypoglycemia in animal versions.[67]If you're residing with style two diabetes